A Greenville youth takes an unexpected Type 1 diabetes diagnosis in stride.
The price of insulin has jumped 400 percent over the past decade, leaving some patients choosing between food and medicine.
FDA approves first continuous glucose monitoring system for treatment decisions, sparing folks from three daily fingersticks.
The answer may be a resounding yes, but you don’t have to make that difficult decision alone.
Middle-aged adults will lose more than 3 years because of the disease, study estimates.
But it's not all good news: The U.S. still has more diabetes patients than 37 other developed nations.
Coming to grips with her diagnosis, Nicole Etrheim got busy, learning about diabetes, adjusting her lifestyle and networking with others.
Learn what’s new, what’s coming up and why so many of us should still get tested.
Join our mailing list and we'll deliver our best stories to your inbox, for free!
We'll never share your email with anyone else.